selegiline 5mg/5ml oral solution
special order - selegiline hydrochloride - oral solution - 1mg/1ml
selegiline 10mg tablets
phoenix healthcare distribution ltd - selegiline hydrochloride - oral tablet - 10mg
selegiline 10mg tablets
waymade healthcare plc - selegiline hydrochloride - oral tablet - 10mg
selegiline 10mg tablets
tillomed laboratories ltd - selegiline hydrochloride - oral tablet - 10mg
selegiline 10mg tablets
mawdsley-brooks & company ltd - selegiline hydrochloride - oral tablet - 10mg
selegiline 10mg/5ml oral solution
special order - selegiline hydrochloride - oral solution - 2mg/1ml
selegiline 5mg tablets
imported - selegiline hydrochloride - oral tablet - 5mg
selegiline 10mg tablets
imported - selegiline hydrochloride - oral tablet - 10mg
trazodone hydrochloride tablet
teva pharmaceuticals usa, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://wome
trazodone hydrochloride tablet
pd-rx pharmaceuticals, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 150 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions ( 5.2), drug interactions ( 7.1)]. patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions ( 5.2), drug interactions ( 7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to registe